| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Brittany Child, Isaac Saywell, Robyn da Silva, Lyndsey Collins-Praino, Irina Baet. Cognitive function in different motor subtypes of Parkinson's disease: A systematic review protocol. Health science reports. vol 7. issue 5. 2024-05-06. PMID:38706802. |
whilst classified as a movement disorder, this disease is highly heterogeneous, encompassing a broad range of both motor and non-motor symptoms (nms). |
2024-05-06 |
2024-05-08 |
Not clear |
| Valton Costa, Alice de Oliveira Barreto Suassuna, Thanielle Souza Silva Brito, Thalita Frigo da Rocha, Anna Carolyna Gianlorenc. Physical exercise for treating non-motor symptoms assessed by general Parkinson's disease scales: systematic review and meta-analysis of clinical trials. BMJ neurology open. vol 5. issue 2. 2023-10-09. PMID:37808516. |
parkinson's disease is a movement disorder that also manifests non-motor symptoms (nms). |
2023-10-09 |
2023-10-15 |
Not clear |
| Esther Cubo, Sheng Luo, Pablo Martínez-Martín, Glenn T Stebbins, Jeffrey Lin, Dongrak Choi, Alvaro García-Bustillo, Pablo Mir, Diego Santos-Garcia, Marcos Serrano-Dueñas, Mayela Rodriguez-Violante, Carlos Singe. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale. Movement disorders clinical practice. vol 10. issue 4. 2023-04-18. PMID:37071078. |
the movement disorder society-sponsored non-motor rating scale (mds-nms) assess the severity and disability caused by non-motor symptoms (nms) in parkinson's disease (pd). |
2023-04-18 |
2023-08-14 |
Not clear |
| Alexander Brenner, Lucas Plagwitz, Michael Fujarski, Tobias Warnecke, Julian Varghes. Utilizing a Non-Motor Symptoms Questionnaire and Machine Learning to Differentiate Movement Disorders. Studies in health technology and informatics. vol 294. 2022-05-25. PMID:35612025. |
here, we evaluate the diagnostic potential of the non-motor symptoms (nms) questionnaire by the international parkinson and movement disorder society based on patient-completed answers from a large single-center prospective study. |
2022-05-25 |
2023-08-13 |
human |
| Gianluigi Rosario Palmieri, Giovanna De Michele, Margherita Matarazzo, Fabiola Di Dato, Sandra Perillo, Diletta Carmen Paola Dello Iacovo, Nunzia Cuomo, Chiara Pane, Cinzia Valeria Russo, Raffaele Iorio, Giuseppe De Michele, Anna De Ros. Prevalence and features of non-motor symptoms in Wilson's disease. Parkinsonism & related disorders. vol 95. 2022-01-30. PMID:35093711. |
movement disorders are the core neurological features, although non-motor symptoms (nms), as cognitive/affective, autonomic and sleep disorders, may occur over time. |
2022-01-30 |
2023-08-13 |
human |
| Shyamal H Mehta, Rajesh Pahwa, Caroline M Tanner, Robert A Hauser, Reed Johnso. Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia. Neurology and therapy. vol 10. issue 1. 2021-06-04. PMID:33864229. |
we report treatment-related effects on non-motor symptoms (nms) assessed as secondary outcomes in two trials using the movement disorder society-unified parkinson's disease rating scale (mds-updrs) part i. |
2021-06-04 |
2023-08-13 |
Not clear |
| Rwei-Ling Yu, Ruey-Meei Wu, Anne Y Y Chan, Vincent Mok, Yih-Ru Wu, Barbara C Tilley, Sheng Luo, Lu Wang, Nancy R LaPelle, Glenn T Stebbins, Christopher G Goet. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale. Movement disorders clinical practice. vol 4. issue 1. 2020-10-01. PMID:28345011. |
given the importance of ethnic differences in the evaluation of various aspects of symptoms in patients with parkinson's disease (pd), we present the formal procedure for completing the traditional chinese translation of the international and parkinson and movement disorder society/updrs (mds-updrs) and highlight the discrepancy in nonmotor symptoms (nms) between patients in eastern and western countries. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ka-Kit Chua, Adrian Wong, Kam-Wa Chan, Yin-Kei Lau, Zhao-Xiang Bian, Jia-Hong Lu, Liang-Feng Liu, Lei-Lei Chen, Ka-Ho Chan, Kim-Pong Tse, Anne Chan, Ju-Xian Song, Justin Wu, Li-Xing Zhu, Vincent Mok, Min L. A Randomized Controlled Trial of Chinese Medicine on Nonmotor Symptoms in Parkinson's Disease. Parkinson's disease. vol 2017. 2020-10-01. PMID:28630780. |
outcome measures were baseline to week 32 changes in movement disorder society-sponsored revision of unified pd rating scale (mds-updrs) parts i-iv and in nms assessment scale for pd (nmss). |
2020-10-01 |
2023-08-13 |
Not clear |
| Eldbjørg Hustad, Jan O Aasl. Clinical and Imaging Markers of Prodromal Parkinson's Disease. Frontiers in neurology. vol 11. 2020-09-28. PMID:32457695. |
today, we consider pd to be not just a movement disorder, but rather a complex syndrome non-motor symptoms (nms) including disorders of sleep-wake cycle regulation, cognitive impairment, disorders of mood and affect, autonomic dysfunction, sensory symptoms and pain. |
2020-09-28 |
2023-08-13 |
Not clear |
| Nataliya Titova, K Ray Chaudhur. Non-motor Parkinson disease: new concepts and personalised management. The Medical journal of Australia. vol 208. issue 9. 2019-06-05. PMID:29764353. |
clinical assessment of nms should include the nms questionnaire (completed by patients) for screening, as recommended by the international parkinson and movement disorders society and other international societies. |
2019-06-05 |
2023-08-13 |
Not clear |
| Shahid Mukhtar, Rashid Imran, Mohsin Zaheer, Huma Tari. Frequency of non-motor symptoms in Parkinson's disease presenting to tertiary care centre in Pakistan: an observational, cross-sectional study. BMJ open. vol 8. issue 5. 2019-04-25. PMID:29769252. |
to determine the frequency of non-motor symptoms (nms) in patients of parkinson's disease (pd) presenting to a movement disorder clinic at a tertiary care centre in pakistan, and how frequency of nms is different in male and female patients. |
2019-04-25 |
2023-08-13 |
Not clear |
| Carla Masala, Paolo Solla, A Liscia, G Defazio, L Saba, A Cannas, A Cavazzana, T Hummel, A Haehne. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease. Journal of neurology. vol 265. issue 8. 2018-10-30. PMID:29804147. |
although parkinson's disease (pd) is usually considered as a movement disorder, it is strongly associated with non-motor symptoms (nms), including smell and taste dysfunctions, cognitive impairment, apathy, fatigue, and autonomic dysregulation. |
2018-10-30 |
2023-08-13 |
human |
| Paulo Bugalho, Tânia Lampreia, Rita Miguel, Marcelo D Mendonça, André Caetano, Raquel Barbos. Non-Motor symptoms in Portuguese Parkinson's Disease patients: correlation and impact on Quality of Life and Activities of Daily Living. Scientific reports. vol 6. 2018-05-23. PMID:27573215. |
we assessed all pd patients attending a portuguese tertiary movement disorders center during one year (n = 134), with adl, hrql and other clinical scales approved for identifying the most relevant nms in pd. |
2018-05-23 |
2023-08-13 |
Not clear |
| Takuya Konno, Rana Hanna Al-Shaikh, Angela B Deutschländer, Ryan J Uitt. Biomarkers of Nonmotor Symptoms in Parkinson's Disease. International review of neurobiology. vol 133. 2018-04-26. PMID:28802922. |
recently, research criteria for prodromal pd, defined as presence of motor and/or nms, but not yet fulfilling the classic pd diagnosis, have been proposed by the international parkinson and movement disorder society task force. |
2018-04-26 |
2023-08-13 |
Not clear |
| Anna Sauerbier, Peter Jenner, Antoniya Todorova, K Ray Chaudhur. Non motor subtypes and Parkinson's disease. Parkinsonism & related disorders. vol 22 Suppl 1. 2016-09-12. PMID:26459660. |
in part this has led the international parkinson and movement disorder society (ipmds) task force to attempt a re-definition of pd incorporating nms and not base the diagnosis solely on motor symptoms. |
2016-09-12 |
2023-08-13 |
Not clear |
| David A Gallagher, Christopher G Goetz, Glenn Stebbins, Andrew J Lees, Anette Schra. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 27. issue 1. 2012-05-21. PMID:21915909. |
modifications have been made to improve scale properties and represent the breadth of manifestations of pd, particularly nonmotor symptoms (nms), resulting in the movement disorder society's revision of the updrs (mds-updrs). |
2012-05-21 |
2023-08-12 |
Not clear |
| Murat Eren Ozen, Mehmet Yumru, Haluk A Savas, Neslihan Cansel, Hasan Herke. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 8. issue 1. 2007-05-02. PMID:17366349. |
neuroleptic malignant syndrome (nms) is the rarest and most serious of the neuroleptic-induced movement disorders. |
2007-05-02 |
2023-08-12 |
Not clear |
| Ibrahim Abu-Kishk, Michal Toledano, Ahuva Reis, David Daniel, Matitiahu Berkovitc. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic. Journal of toxicology. Clinical toxicology. vol 42. issue 6. 2004-11-26. PMID:15533033. |
neuroleptic malignant syndrome (nms) is an uncommon potentially fatal side effect of neuroleptic drugs, characterized by movement disorder, altered mental status and autonomic instability. |
2004-11-26 |
2023-08-12 |
Not clear |
| M D Freedma. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review. Maryland medical journal (Baltimore, Md. : 1985). vol 46. issue 7. 1997-09-17. PMID:9260471. |
nms is characterized by mental status changes, muscle rigidity (and movement disorders such as dyskinesias and akathisias), leukocytosis, hyperthermia, and autonomic dysfunction. |
1997-09-17 |
2023-08-12 |
Not clear |
| C Harpe, A Stoudemir. Aetiology and treatment of neuroleptic malignant syndrome. Medical toxicology. vol 2. issue 3. 1987-07-27. PMID:3298921. |
the clinical triad of fever, movement disorder, and altered mentation known as nms represents an infrequent yet highly lethal side effect of neuroleptic therapy. |
1987-07-27 |
2023-08-11 |
Not clear |